EXPERT OPINION ON THE MANAGEMENT OF HEMORRHOIDAL DISEASE (HD) IN INDIA - 2020-21

Question Title

* 1. Please enter your name below

Question Title

* 2. Please enter city

Question Title

* 3. Please enter your speciality

Question Title

* 4. Date

Date / Time

Date

Time

AM/PM

Question Title

* 5. What is the average number of patients with hemorrhoidal disease (HD) which you treat in a month? (Please tick the appropriate option)

<10

10-25

26-50

>50

Question Title

* 6. Which of the following grades of HD you treat at your own clinic/hospital? (Please tick the appropriate option/s)

Grade I

Grade II

Grade III

Grade IV

Question Title

* 7. What is the average number of patients you treat in a month for the following patient profile ? (Please put a number in the box given against all categories)

Acute haemorrhoids

Haemorrhoids requiring office procedures

Haemorrhoids requiring surgery

Recurrent / chronic haemorrhoids

Question Title

* 8. In which profile of patients (from those given above), do you find Micronized Purified Flavonoid Fraction (MPFF) most useful? (Please write 2 patient profiles in the order of priority in the blanks given below)

Question Title

* 9. What are your 3 main reasons for prescribing MPFF in your patients with HD? (Please choose only 3 options and rank them in order in the given box)

a) Rapid action

b) Strong efficacy in controlling bleeding

c) Convenient option Vs suppositories / topical agents

d) Prevention of recurrence

e) Strong guideline recommendation

f) Documentation and evidence

g) Natural origin

h) Other

Question Title

* 10. Do you agree with the statement that the MICRONIZATION process, involved in the manufacturing of MPFF, does influence the efficacy of MPFF in your patients with HD?

Yes

Question Title

* 11. The UNIQUE composition of MPFF, synergy of 5 flavonoids is responsible for the significant patient benefits of MPFF in your patients with HD. (Please mention your feedback below as a clinical expert)

Question Title

* 12. What is the average dose and duration of prescribing MPFF 1000mg in your patients with acute haemorrhoidal attack?

a) BID for 5 days

b) TID for 7 days

c) BID for 7 days

d) TID for 4 days, followed by BID for 3 days

e) Other (please specify)

Question Title

* 13. What is the average dose and duration of prescribing MPFF 1000mg for prevention of relapses in your patients with recurrent / chronic haemorrhoids?

a) OD for 2 weeks

b) OD for 4 weeks

c) OD for 6 weeks

d) OD for 2 months

e) OD for 3 months

Other (please specify)

Question Title

* 14. Are you shifting to the new 1000mg of MPFF from 500mg for your HD patients?

Yes

EXPERT OPINION ON THE MANAGEMENT OF HEMORRHOIDAL DISEASE (HD) IN INDIA - 2020-21

Question Title

* 1. Please enter your name below

Question Title

* 2. Please enter city

Question Title

* 3. Please enter your speciality

Question Title

* 4. Date

Question Title

* 5. What is the average number of patients with hemorrhoidal disease (HD) which you treat in a month? (Please tick the appropriate option)

Question Title

* 6. Which of the following grades of HD you treat at your own clinic/hospital? (Please tick the appropriate option/s)

Question Title

* 7. What is the average number of patients you treat in a month for the following patient profile ? (Please put a number in the box given against all categories)

Question Title

* 8. In which profile of patients (from those given above), do you find Micronized Purified Flavonoid Fraction (MPFF) most useful? (Please write 2 patient profiles in the order of priority in the blanks given below)

Question Title

* 9. What are your 3 main reasons for prescribing MPFF in your patients with HD? (Please choose only 3 options and rank them in order in the given box)

Question Title

* 10. Do you agree with the statement that the MICRONIZATION process, involved in the manufacturing of MPFF, does influence the efficacy of MPFF in your patients with HD?

Question Title

* 11. The UNIQUE composition of MPFF, synergy of 5 flavonoids is responsible for the significant patient benefits of MPFF in your patients with HD. (Please mention your feedback below as a clinical expert)

Question Title

* 12. What is the average dose and duration of prescribing MPFF 1000mg in your patients with acute haemorrhoidal attack?

Question Title

* 13. What is the average dose and duration of prescribing MPFF 1000mg for prevention of relapses in your patients with recurrent / chronic haemorrhoids?

Question Title

* 14. Are you shifting to the new 1000mg of MPFF from 500mg for your HD patients?

Question Title

* 15. If no, what are your reasons (Please put a maximum of 3 reasons in the order of priority)

Question Title

* 16. On the scale of 1-10, how likely are you to recommend MPFF as the preferred treatment of choice in HD?